Tesaglitazar, a Dual Peroxisome Proliferator- Activated Receptor Agonist (PPARα/γ), Improves Metabolic Abnormalities and Reduces Renal Injury in Obese Zucker Rats

Publisher: Karger

E-ISSN: 1660-2129|114|2|e61-e68

ISSN: 1660-2129

Source: Nephron Experimental Nephrology, Vol.114, Iss.2, 2009-11, pp. : e61-e68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract